These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37966571)

  • 1. Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.
    Khosravi MA; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3477-3491. PubMed ID: 37966571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
    Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
    [No Abstract]   [Full Text] [Related]  

  • 3. Curcumin in Cancer Prevention: Insights from Clinical Trials and Strategies to Enhance Bioavailability.
    Alam S; Lee J; Sahebkar A
    Curr Pharm Des; 2024; 30(23):1838-1851. PubMed ID: 38808709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
    Frassová Z; Rudá-Kučerová J
    Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
    Basnet P; Skalko-Basnet N
    Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: bioavailability and efficacy of 'free' curcuminoids from curcumagalactomannoside (CGM) curcumin formulation.
    Matthewman C; Krishnakumar IM; Swick AG
    Nutr Res Rev; 2024 Jun; 37(1):14-31. PubMed ID: 36655498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies.
    Douglass BJ; Clouatre DL
    J Am Coll Nutr; 2015; 34(4):347-58. PubMed ID: 25856323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
    Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
    J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
    Gota VS; Maru GB; Soni TG; Gandhi TR; Kochar N; Agarwal MG
    J Agric Food Chem; 2010 Feb; 58(4):2095-9. PubMed ID: 20092313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin: a boon to colonic diseases.
    Sareen R; Jain N; Pandit V
    Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A; Wahid F; Lee YS
    Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study.
    Thanawala S; Shah R; Alluri KV; Somepalli V; Vaze S; Upadhyay V
    J Pharm Pharmacol; 2021 Apr; 73(6):816-823. PubMed ID: 33755149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability.
    Abd El-Hack ME; El-Saadony MT; Swelum AA; Arif M; Abo Ghanima MM; Shukry M; Noreldin A; Taha AE; El-Tarabily KA
    J Sci Food Agric; 2021 Nov; 101(14):5747-5762. PubMed ID: 34143894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of curcumin in digestive diseases.
    Dulbecco P; Savarino V
    World J Gastroenterol; 2013 Dec; 19(48):9256-70. PubMed ID: 24409053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: Curcumin.
    Di Martino RM; Luppi B; Bisi A; Gobbi S; Rampa A; Abruzzo A; Belluti F
    Expert Opin Ther Pat; 2017 May; 27(5):579-590. PubMed ID: 28024125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.